查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2020694

大便潛血試驗全球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Fecal Occult Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，大便潛血試驗市場規模將達到 27.6 億美元，高於 2025 年的 17.1 億美元，預計從 2026 年到 2034 年的複合年成長率將達到 5.46%。

隨著全球對早期發現胃腸道疾病和大腸癌重要性的認知不斷提高，大便潛血試驗的全球市場正在擴大。大便潛血試驗用於檢測糞便樣本中的隱血，這可能預示著消化系統疾病或大腸癌的早期階段。醫療專業人員廣泛建議將此檢測納入常規篩檢項目，尤其適用於老年人和高風險族群。

健康意識的提高和預防性篩檢計畫的擴展是市場成長的主要驅動力。各國政府和醫療機構正在推廣大腸癌篩檢，以提高早期診斷和治療效果。此外，診斷技術的進步也提高了大便潛血試驗試驗的準確性和可靠性。

隨著醫療保健系統日益重視預防醫學和疾病早期檢測，大便潛血試驗市場預計將進一步擴大。先進檢測套組和居家篩檢方案的開發，使患者更容易獲得這些檢測。此外，新興國家醫療基礎設施的改善和篩檢措施的推廣，也可能推動市場持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球大便潛血試驗市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 癒創木脂法大便潛血試驗
  • 免疫FOB凝集法
  • 側向流免疫療法 FOB 檢測
  • 免疫球蛋白ELISA檢測

第5章：全球大便潛血試驗市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 診斷中心
  • 其他

第6章：全球大便潛血試驗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Humasis.Com
    • CTK Biotech Inc
    • Biopanda Reagents Ltd
    • Biohit Oyj
    • Certest Biotec
    • Cenogenics Corporation
    • Alfa Scientific Designs Inc
    • Siemens Healthcare GmbH
    • Jant Pharmacal Corporation
    • Quidel Corporation
    • Wondfo
簡介目錄
Product Code: VMR112117554

The Fecal Occult Testing Market size is expected to reach USD 2.76 Billion in 2034 from USD 1.71 Billion (2025) growing at a CAGR of 5.46% during 2026-2034.

The global fecal occult testing market is growing as awareness about early detection of gastrointestinal diseases and colorectal cancer increases worldwide. Fecal occult tests are used to detect hidden blood in stool samples, which can indicate digestive disorders or early-stage colorectal cancer. Healthcare providers widely recommend these tests as part of routine screening programs, especially for older adults and high-risk individuals.

Increasing healthcare awareness and the expansion of preventive screening programs are major factors supporting market growth. Governments and healthcare organizations are promoting colorectal cancer screening initiatives to improve early diagnosis and treatment outcomes. Additionally, advancements in diagnostic technologies are improving the accuracy and reliability of fecal occult testing methods.

In the future, the fecal occult testing market is expected to expand further as healthcare systems emphasize preventive care and early disease detection. The development of advanced testing kits and home-based screening solutions is making these tests more accessible to patients. Moreover, increasing healthcare infrastructure and screening initiatives in emerging economies are likely to drive sustained market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Guaiac FOB stool test
  • Immuno-FOB agglutination test
  • Lateral flow immuno-FOB test
  • Immuno-FOB ELISA test

By End-use

  • Hospitals
  • Diagnostic centers
  • Others

COMPANIES PROFILED

  • HumasisCom, CTK Biotech Inc, Biopanda Reagents Ltd, Biohit Oyj, Certest Biotec, Cenogenics Corporation, Alfa Scientific Designs Inc, Siemens Healthcare GmbH, Jant Pharmacal Corporation, Quidel Corporation, Wondfo
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL FECAL OCCULT TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Guaiac FOB stool test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Immuno-FOB agglutination test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Lateral flow immuno-FOB test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Immuno-FOB ELISA test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL FECAL OCCULT TESTING MARKET: BY END-USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-use
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Diagnostic centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL FECAL OCCULT TESTING MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By End-use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By End-use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By End-use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By End-use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By End-use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL FECAL OCCULT TESTING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Humasis.Com
    • 8.2.2 CTK Biotech Inc
    • 8.2.3 Biopanda Reagents Ltd
    • 8.2.4 Biohit Oyj
    • 8.2.5 Certest Biotec
    • 8.2.6 Cenogenics Corporation
    • 8.2.7 Alfa Scientific Designs Inc
    • 8.2.8 Siemens Healthcare GmbH
    • 8.2.9 Jant Pharmacal Corporation
    • 8.2.10 Quidel Corporation
    • 8.2.11 Wondfo